- $5.45bn
- $5.64bn
- $3.76bn
- 90
- 56
- 54
- 73
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,131 | 1,900 | 3,075 | 3,806 | 3,758 |
Cost of Revenue | |||||
Gross Profit | 381 | 423 | 750 | 946 | 1,142 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,030 | 2,612 | 2,902 | 3,554 | 3,265 |
Operating Profit | 101 | -712 | 173 | 252 | 494 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 59.2 | -763 | 153 | 197 | 424 |
Provision for Income Taxes | |||||
Net Income After Taxes | 53 | -742 | 114 | 157 | 319 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 52.2 | -744 | 113 | 155 | 314 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 52.2 | -744 | 113 | 155 | 314 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.851 | -1.67 | 0.592 | 1.22 | 1.64 |
Dividends per Share |